相关实验视频

Updated: Jun 16, 2026

Dynamic Quantitative Sensory Testing to Characterize Central Pain Processing

Dynamic Quantitative Sensory Testing to Characterize Central Pain Processing

Published on: February 16, 2017

人类感冒疼痛:一个随机交叉试验

Felix J Resch¹, Stefan Heber¹, Farzin Shahi¹

¹Center for Physiology and Pharmacology, Medical University of Vienna, Vienna, Austria.

|December 18, 2024

概括

研究人类感冒疼痛机制,这项研究发现,阻断TRPA1,TRPM8和NaV1.7等关键通道并没有消除感冒疼痛,但降低了感知其温度值.

科学领域:

神经科学是一个神经科学.
疼痛研究疼痛研究
分子生物学分子生物学

背景情况:

人类感冒疼痛背后的精确分子机制尚不清楚.
动物研究表明,在冷检测中涉及过渡受体潜在通道 (TRPM8,TRPA1),在信号传导中涉及电压关闭通道 (NaV1.7,NaV1.8).

研究的目的:

通过使用一种新的皮内注射模型,研究TRPM8,TRPA1,NaV1.7和NaV1.8在人类感冒疼痛感知中的作用.
为了确定阻断这些通道是否可以减轻感冒引起的疼痛.

主要方法:

在36名人类志愿者身上开发一种基于皮内注射的感冒疼痛模型.
在双盲交叉设计中使用抗剂对TRPM8,TRPA1,NaV1.7和NaV1.8进行药理阻塞.
利多卡因作为减轻疼痛的积极对照.

主要成果:

利多卡因显著降低了感冒引起的疼痛.
阻断单个或组合的TRPM8,TRPA1,NaV1.7和NaV1.8通道并没有显著减少感冒疼痛的强度.
抑制TRPA1,TRPM8和NaV1.7,以及在较小程度上NaV1.8,将寒冷疼痛温度值向下移动高达5.8°C.

结论:

研究的道 (TRPM8,TRPA1,NaV1.7,NaV1.8) 不仅仅负责人类感冒疼痛的检测或传导.
这些通道似乎调节了感知寒冷疼痛的温度值.
导致人体感冒疼痛的其他分子机制需要进一步调查.

关键词:

感冒疼痛感冒疼痛感冒疼痛人类疼痛模型疼痛值疼痛值疼痛值疼痛值随机对照试验是随机对照试验.感官神经元是一种神经元.在 TRPA1 中,在TRPM8中,我们可以使用TRPM8.

更多相关视频

Determining Pain Detection and Tolerance Thresholds Using an Integrated, Multi-Modal Pain Task Battery

Determining Pain Detection and Tolerance Thresholds Using an Integrated, Multi-Modal Pain Task Battery

Published on: April 14, 2016

Determining heat and mechanical pain threshold in inflamed skin of human subjects

Determining heat and mechanical pain threshold in inflamed skin of human subjects

Published on: January 14, 2009

相关概念视频

Crossover Experiments

Crossover Experiments

Crossover experiments, also called the repeated-measurements design, is a study design in which all experimental units are exposed to all treatments in different periods. Crossover experiments are generally used in psychology, the pharmaceutical industry, agriculture, and medicine.
Crossover designs are performed even with smaller sample sizes since the samples can act as their controls. These are better than simple randomized trials since patients are exposed to all the treatments.